Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway

Bibliographic Details
Main Authors:	Zhou Guo, Jiamin Lin, Kai Sun, Jiayou Guo, Xudong Yao, Genchun Wang, Liangcai Hou, Jingting Xu, Jiachao Guo, Fengjing Guo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Pharmacology
Subjects:	osteoarthritis chondrocytes ferroptosis deferoxamine Nrf2
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1199951/full

Internet